Although serum CEA had long been accepted as the most important and reliable prognostic factor in CRC, it had been reported that 20–30% of patients with CRC failed to produce elevated serum levels, which was considered as one of the major limitations in monitoring [12, 14]. Here, CEACAM5 is linked to colorectal carcinoma.